Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, discusses what people diagnosed with myeloproliferative neoplasms (MPN) need to consider when choosing among providers and treatment options.
Gabriela Hobbs, M.D., discusses how to manage symptoms associated with a myeloproliferative neoplasm diagnosis.
Lindsey M. Lyle, M.S., offers advice to patients with newly diagnosed myeloproliferative neoplasms.
Barbara Abernathy, Ph.D., CEO of the Pediatric Oncology Support Team, explains how she is inspired by her work with children who have cancer.
Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.
Julia Nangia, M.D., assistant professor at Baylor College of Medicine, discusses the impact that chemotherapy-related hair loss can have on patients with breast cancer.
David R. Gandara, M.D., UC Davis Comprehensive Cancer Center, discusses how diagnostic and therapeutic changes are happening alongside one another in non-small cell lung cancer.
Oliver Dorigo, M.D., Ph.D., Associate Professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, talks about the direction of research in the ovarian cancer field going into 2018 and beyond.
Halle Moore, M.D., physician at Department of Solid Tumor Oncology at Cleveland Clinic Taussig Cancer Institute, discusses fertility preservation in women with breast cancer.
Oliver Dorigo, M.D., Ph.D., associate professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, discusses the lack of effective screening methods for ovarian cancer.
Oliver Dorigo, M.D., Ph.D., Associate Professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, discusses recent exciting developments in the ovarian cancer field.
When facing ovarian cancer, it is critical to stay healthy and well-informed, says Anya Khomenko.
Cancer survivors should speak up about any kind of sexual issues they're having during or after treatment.
Jim Kelly, NFL Hall of Famer, discusses how much a smile or a kind word can mean to someone with cancer – and he knows from experience.
Can local and systemic therapies be combined to treat liver cancer?
Thomas Butler, M.D., medical oncologist at the University of Southern Alabama, Mitchell Cancer Institute, discusses the importance of shared decision making in cancer care.
There seems to be a shift in the field of oncology where patients are looking more toward being treated close to home rather than traveling to a large academic treatment center, explained Edward S. Kim, M.D., Chair of the Department of Solid Tumor Oncology at Levine Cancer Institute, at Association of Community Cancer Centers 34th National Oncology Conference.
Ashley Johnson, patient wellness navigator at Charleston Hematology and Oncology Associates, discusses how important it is for the whole health care team to better understand insurance and how patients pay for their cancer treatment.
Mellisa Wheeler, director of Disparities at the Levine Cancer Institute, discusses how her team came to recognize the need for a mobile lung cancer screening unit.
Older patients who are newly diagnosed with cancer often have special needs, says Janine Overcash, Ph.D., associate professor of clinical nursing and director of the Adult/Geriatric Nurse Practitioner Program at The Ohio State University.
Cancer care involves more than just doctors and nurses. Nadine Barrett, director of the Office of Health Equity and Disparities at the Duke Cancer Institute, knows this.
David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, breaks down a common misconception that many people have about glioblastoma (GBM).
Renata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.
Rebecca Arend, M.D., gynecologic oncologist at University of Alabama at Birmingham Hospital, discusses the rapidly changing field of ovarian cancer.
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.
Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.
Yania Jansen, surgical trainee at Vrije Universiteit Brussel, in Brussels, Belgium, discusses the possibility of stopping treatment with Keytruda (pembrolizumab) for patients with melanoma.
David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, offers advice for patients who have recently been diagnosed with glioblastoma (GBM).
Jeffrey Weber, M.D., Ph.D., Deputy Director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses how important it is that patients speak up when they experience side effects from their cancer treatments.
Renee Cowan, gynecologic oncology fellow at Memorial Sloan Kettering Cancer Center (MSK), discusses the importance of patients with ovarian cancer seeing an oncologist who specializes in the field.
